Dr. Gad Heilweil, MD

Dr. Heilweil practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Heilweil's NPI, 1386989440, was assigned on November 30, 2012. Dr. Heilweil graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1998. Dr. Heilweil holds California license A136287.

Dr. Heilweil's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Heilweil's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Heilweil is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Heilweil to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heilweil practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Heilweil's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Heilweil is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Heilweil treats.

CMS data shows 20,203 Medicare services from Dr. Heilweil across 13 procedure codes in 2024, for 1,169 Medicare patients. Medicare paid $2,201,136 for them. Every service was in an office.

CMS counts 1,169 Medicare patients who saw Dr. Heilweil in 2024. The largest group is 75 to 84, with 458 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Heilweil's median patient age at 68, with 57% women.

In 2024, Dr. Heilweil wrote 375 Medicare Part D claims for 127 patients. 45% of them were for generic drugs. CMS names the drug for 314 of them, across 10 drugs with 11 or more claims each, at $49,978 in total drug cost. In 2023, CMS named 226 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Heilweil for performance year 2024, reported as part of a group. Dr. Heilweil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Heilweil, published from 2013 to 2022. 2022 was the busiest year, with 2. Dr. Heilweil's most frequent co-authors are Steven Daniel Schwartz, MD, Vikas Chopra, MD and Peter George Dentone, MD.

CMS Open Payments shows 50 general payments to Dr. Heilweil from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Astellas Pharma US Inc paid the most, $242.

Dr. Heilweil graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1998.

Dr. Heilweil is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.